Inhibition of hypoxia-inducible factor-1 by Salidroside in an in vitro model of choroidal neovascularization
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of hypoxia-inducible factor-1 by Salidroside in an in vitro model of choroidal neovascularization
Authors
Keywords
-
Journal
Cutaneous and Ocular Toxicology
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2021-08-25
DOI
10.1080/15569527.2021.1973023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salidroside ameliorated hypoxia‐induced tumorigenesis of BxPC‐3 cells via downregulating hypoxia‐inducible factor (HIF)‐1α and LOXL2
- (2019) Xiaoping Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Salidroside inhibits high-glucose induced proliferation of vascular smooth muscle cells via inhibiting mitochondrial fission and oxidative stress
- (2017) Xinyu Zhuang et al. Experimental and Therapeutic Medicine
- Protective effect of salidroside against bone loss via hypoxia-inducible factor-1α pathway-induced angiogenesis
- (2016) Ling Li et al. Scientific Reports
- The cardioprotective effect of salidroside against myocardial ischemia reperfusion injury in rats by inhibiting apoptosis and inflammation
- (2015) Lingpeng Zhu et al. APOPTOSIS
- Vascular Endothelial Growth Factor Receptor 2 Antibody, BC001, Attenuates Laser-Induced Choroidal Neovascularization in Rhesus Monkeys (Macaca mulatta)
- (2015) Tao Zhao et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Salidroside attenuates lipopolysaccharide (LPS) induced serum cytokines and depressive-like behavior in mice
- (2015) Lingpeng Zhu et al. NEUROSCIENCE LETTERS
- Molecular pathogenesis of retinal and choroidal vascular diseases
- (2015) Peter A. Campochiaro PROGRESS IN RETINAL AND EYE RESEARCH
- Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway
- (2015) Sha-Sha Xing et al. VASCULAR PHARMACOLOGY
- Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis
- (2014) Sunday S. Oladipupo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD44 regulates vascular endothelial barrier integrity via a PECAM-1 dependent mechanism
- (2013) Kelly M. Flynn et al. ANGIOGENESIS
- Cellular and molecular mechanisms of age-related macular degeneration: From impaired autophagy to neovascularization
- (2013) Alexa Klettner et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An immunologist's guide to CD31 function in T-cells
- (2013) F. M. Marelli-Berg et al. JOURNAL OF CELL SCIENCE
- Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
- (2013) Georgios Panos et al. Drug Design Development and Therapy
- Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex
- (2012) Imran Bhutto et al. MOLECULAR ASPECTS OF MEDICINE
- Incidence of Endophthalmitis and Use of Antibiotic Prophylaxis after Intravitreal Injections
- (2012) Crystal S.Y. Cheung et al. OPHTHALMOLOGY
- Introduction: Understanding the Role of Angiogenesis and Antiangiogenic Agents in Age-Related Macular Degeneration
- (2009) Susan B. Bressler OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started